Chem
J-GLOBAL ID:200907018220566028   Nikkaji number:J6.892F

Ouabain

ウアバイン
Substance type:
Substance type
Substance type classified into 3 categories.
Decided structure: Substances with a clear structure
Undicided Structure: Substances with unknown or undetermined structure
Mixtures: Mixtures, racemic compounds, or compounds with relative structural arrangements
Decided structure
Molecular formula: C29H44O12
Molecular formula furigana: C29-H44-O12
Molecular weight: 584.659
InChI: InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1
InChI key: LPMXVESGRSUGHW-HBYQJFLCSA-N
SMILES: C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O
Systematic name  (5):
  • 3β-[(6-デオキシ-α-L-マンノピラノシル)オキシ]-1β,5,11α,14,19-ペンタヒドロキシ-5β,14β-カルダ-20(22)-エノリド
  • 3β-[(6-デオキシ-α-L-マンノピラノシル)オキシ]-1β,5,11α,14,19-ペンタヒドロキシ-5β-カルダ-20(22)-エノリド
  • 1β,5,11α,14,19-ペンタヒドロキシ-3β-(α-L-ラムノピラノシルオキシ)-5β,14β-カルダ-20(22)-エノリド
  • 4-[(1R,3aS,3bR,5aS,7S,9R,9aR,9bS,10R,11aR)-3a,5a,9,10-テトラヒドロキシ-9a-(ヒドロキシメチル)-11a-メチル-7-{[(2R,3R,4R,5R,6S)-3,4,5-トリヒドロキシ-6-メチルオキサン-2-イル]オキシ}-ヘキサデカヒドロ-1H-シクロペンタ[a]フェナントレン-1-イル]-2,5-ジヒドロフラン-2-オン
  • 4-[(1R,3aS,3bR,5aS,7S,9R,9aR,9bS,10R,11aR)-3a,5a,9,10-tetrahydroxy-9a-(hydroxymethyl)-11a-methyl-7-{[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one
Other name (13):
  • ウアバイン
  • ストロジバル
  • ストロジバール
  • g-ストロファンチン
  • Ouabain
Show all
CAS registry number: 630-60-4
Regulation number (3):
  • EINECS2111393
  • RN3850000
  • TSCA(630-60-4)
KEGG COMPOUND: C01443
Application (2):
cardiac glycoside ,  derived lipid
Thsaurus map:

Return to Previous Page